-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QluBMWhAD6flUzTS7RFIu+E8WPf7S49Bb0VdtSkr1kA2hVAdWvv9ImGsfDsYuoKN iT7XxpgK+CkJZId11ATD0w== 0001144204-08-012720.txt : 20080229 0001144204-08-012720.hdr.sgml : 20080229 20080229170254 ACCESSION NUMBER: 0001144204-08-012720 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080227 FILED AS OF DATE: 20080229 DATE AS OF CHANGE: 20080229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeoStem, Inc. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-584-4171 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 FORMER COMPANY: FORMER CONFORMED NAME: CORNICHE GROUP INC /DE DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY MEDICAL INC DATE OF NAME CHANGE: 19951025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VACZY CATHERINE M CENTRAL INDEX KEY: 0001177176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 08656741 BUSINESS ADDRESS: STREET 1: IMCLONE SYSTEMS INC STREET 2: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 631-574-4955 MAIL ADDRESS: STREET 1: C/O PHASE III MEDICAL, INC. STREET 2: 330 SOUTH SERVICE ROAD, SUITE 120 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 v105476_ex.xml X0202 4 2008-02-27 0 0000320017 NeoStem, Inc. NBS 0001177176 VACZY CATHERINE M C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170 0 1 0 0 VP and General Counsel Stock Options (right to buy) 1.63 2008-02-27 4 A 0 36000 0 A 2018-02-26 Common Stock, par value $.001 per share 36000 36000 D On February 27, 2008, the date of grant ("Grant Date"), Ms. Vaczy was granted an option to purchase 36,000 shares of common stock of NeoStem, Inc. (the "Company"), pursuant to and subject to the Company's 2003 Equity Participation Plan. 10,000 of these options vested on the Grant Date and 26,000 options shall vest upon the achievement of certain specified business milestones. /s/ Catherine M. Vaczy 2008-02-29 -----END PRIVACY-ENHANCED MESSAGE-----